Results 91 to 100 of about 706,173 (166)
Articular involvement in juvenile localized scleroderma [PDF]
Osminina MK, Geppe NA, Shpitonkova OV
openaire +1 more source
Methotrexate and Mycophenolate Mofetil and Clinical Response in Juvenile Localized Scleroderma
Importance Currently, there are no treatments approved by the US Food and Drug Administration for juvenile localized scleroderma (JLS), a rare disease. While methotrexate (MTX) is regularly used as a first-line therapy, emerging data from case series and applications in systemic sclerosis suggest that ...
de Rosas, Elena C. +3 more
openaire +2 more sources
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source
Localized scleroderma: case report and literature review. [PDF]
Background. Localized scleroderma is a rare chronic autoimmune inflammatory disorder, belonging to the spectrum of sclerosing skin diseases, affecting patients of any age, more frequently Caucasian females.
Pargaliauskaitė, Julija,
core
application/pdf; "November 2015."; Includes bibliographical references."Two recent reports called attention to the high costs and unsatisfactory outcomes of Kansas’s juvenile justice system. ...
Kansas Juvenile Justice Workgroup.
core +1 more source
Other title: Statistics on the Juvenile Offender Population
application/pdfA set of 11 documents provided by the Juvenile Services Division of the Kansas Department of Corrections and its predecessor, the Kansas Juvenile Justice Authority, with Statistics on the Juvenile Offender Population.FY 2009-2012 Judicial ...
Kansas. Department of Corrections. Division of Juvenile Services.
core
Other title: Final Report : Executive Summary; Other title: Executive Summary
application/pdf; Includes bibliographical references."Established in June 2015, the bipartisan, inter-branch Kansas Juvenile Justice Workgroup consisted of 17 representatives from all parts of the juvenile justice system, including judges, district ...
Kansas Juvenile Justice Workgroup.
core +1 more source
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, necessitating further cellular and molecular level studies.
Theresa Hutchins +17 more
core +1 more source
Congenital localized scleroderma
Objectives Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS).
Zulian , F.
core

